A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Cancer Institute (NCI)
Terremoto Biosciences Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
Avenzo Therapeutics, Inc.
University Hospital, Gasthuisberg
AstraZeneca